KYT (Know Your Truth) is a comprehensive health testing platform designed to detect the earliest biological signals of disease through genomics, inflammation mapping, hereditary cancer screening, and pharmacogenomic testing—all from one simple blood draw.
Unlike traditional genetic tests that focus on a single area, KYT integrates multiple key panels—Liquid Biopsy (LB), Hereditary Cancer (HerCan), Pharmacogenomics (PGx), and Ancestry—into one streamlined test. This gives you a more complete picture of your health and risk profile, helping you and your physician make proactive, personalized decisions.
KYT is ideal for any adult seeking proactive, preventive healthcare. It's especially beneficial for those with a family history of disease, individuals wanting to optimize their longevity and wellness, or patients whose providers emphasize early detection and precision medicine.
Our core package includes:
Results are typically available within 10–14 business days from the time the lab receives your sample.
At this time, KYT is a self-pay service to ensure complete privacy, transparency, and accessibility without the restrictions of traditional billing. Payment options and flexible spending (HSA/FSA) eligibility are available.
Absolutely. Your privacy is our highest priority. KYT complies with the HIPAA standard. Your data is encrypted and never shared, sold, or used for research without explicit consent.
Yes. KYT can be ordered by any licensed healthcare provider or partnered telehealth physician. If you don't have a provider, KYT can connect you with one through our network.
KYT partners with certified clinical laboratories, board-certified genetic counselors, and medical advisors specializing in genomics, oncology, and precision medicine. Our goal is to bring cutting-edge science into a simplified, actionable format.
KYT's Liquid Biopsy panel can detect circulating tumor DNA and other early biomarkers associated with cancer and systemic inflammation. While it is not a diagnostic tool, it can help identify early signals that warrant further medical evaluation.
We recommend annual testing to monitor for changes in biomarker trends and ensure early detection as part of your long-term wellness plan.
Yes! KYT offers gift packages—an empowering way to help loved ones take control of their health.
Visit KYT or contact your KYT representative to order your test and begin your personalized health journey.
KYT (Know Your Truth) is a precision-health platform that integrates genomics, liquid biopsy, inflammation mapping, pharmacogenomics, and hereditary cancer testing into a single, streamlined workflow. Our goal is to simplify advanced preventive testing for clinicians while empowering patients with actionable insights derived from one convenient blood draw.
KYT eliminates the fragmentation of ordering multiple tests from different vendors. Through one unified platform, physicians can access:
KYT is ideal for:
The Core KYT Panel ($1,599) includes:
Physicians can order KYT through:
All testing is performed in CLIA-certified and CAP-accredited laboratories using validated next-generation sequencing (NGS) and biomarker assays. Data is quality-controlled and reviewed by board-certified clinical geneticists prior to report generation.
Results are typically available within 10–14 business days after the lab receives the sample.
Physicians receive a comprehensive digital report that includes:
Yes. Each component test (Hereditary Cancer, PGx, Liquid Biopsy, etc.) has its own associated CPT codes recognized by most commercial payors. A KYT partner representative can provide a CPT coding and billing reference sheet upon request.
KYT currently operates as a self-pay service to allow maximum transparency, privacy, and speed of access. Patients may submit superbills for potential HSA/FSA reimbursement depending on their individual plans.
KYT offers:
KYT adheres to HIPAA, and CLIA compliance standards. All patient data is encrypted, securely stored, and never shared without consent. No third-party research use is permitted unless explicitly authorized by the patient.
Physicians can apply to become a KYT ordering provider by completing a Partner Enrollment Form. Once approved, you'll receive:
Annual re-testing is recommended for continuous health monitoring, particularly for inflammation and liquid biopsy markers, where longitudinal data provides valuable trend analysis.
For clinical or partnership questions, contact:
Lauren Carollo – Head of Client Relations & Sales
📧 lauren@serenomica.com | 📞 631-987-1543